x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Empowered Patient Podcast

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

health & fitness medicine

All Episodes

0:00

Precision Allergy Diagnostics Based on Molecular...

Empowered Patient Podcast ·

2025/04/23

Gary Falcetano, Scientific Affairs Manager for Allergy at Thermo Fisher Scientific, is a leader in allergy and autoimmune diagnostics, providing specific IgE tests and the instruments to run them. Accurately diagnosing allergies can be challenging, but specific IgE testing can help confirm the underlying causes by looking at individual allergen components for precise diagnosis. This is the first step in determining the appropriate management approach to potentially interrupt the atopic march, where

en

18:55

Precision Allergy Diagnostics Based on Molecular...

Empowered Patient Podcast ·

2025/04/23

Gary Falcetano, Scientific Affairs Manager for Allergy at Thermo Fisher Scientific, is a leader in allergy and autoimmune diagnostics, providing specific IgE tests and the instruments to run them. Accurately diagnosing allergies can be challenging, but specific IgE testing can help confirm the underlying causes by looking at individual allergen components for precise diagnosis. This is the first step in determining the appropriate management approach to potentially interrupt the atopic march, where

en

0:00

Human-Centric AgeTech Innovations Support Ecosystem...

Empowered Patient Podcast ·

2025/04/22

Chia-Lin Simmons, CEO of LogicMark, is developing technology solutions to help seniors age independently and safely. Their AgeTech ecosystem addresses the requirements and comfort levels of the diverse aging population and provides predictive technology to identify potential health issues and emergencies. The key is keeping a human-centric approach to the application of this technology and integration with other health monitoring devices and apps. Chia-Lin explains, "At LogicMark, we tell people

en

23:46

Human-Centric AgeTech Innovations Support Ecosystem...

Empowered Patient Podcast ·

2025/04/22

Chia-Lin Simmons, CEO of LogicMark, is developing technology solutions to help seniors age independently and safely. Their AgeTech ecosystem addresses the requirements and comfort levels of the diverse aging population and provides predictive technology to identify potential health issues and emergencies. The key is keeping a human-centric approach to the application of this technology and integration with other health monitoring devices and apps. Chia-Lin explains, "At LogicMark, we tell people

en

0:00

AI-Powered Antibody Drug Discovery for Obesity and...

Empowered Patient Podcast ·

2025/04/21

Martin Brenner, CEO and Chief Scientific Officer of iBio, is focused on the untapped potential of therapeutic antibodies for obesity and cardiometabolic diseases. Leveraging AI and machine learning, iBio is streamlining the antibody discovery and optimization process and addressing the need for more complex antibody mechanisms of action. Their lead candidate, iBio 600, is an anti-myostatin antibody designed to address the side effects of muscle mass and bone density loss associated with current

en

21:56

AI-Powered Antibody Drug Discovery for Obesity and...

Empowered Patient Podcast ·

2025/04/21

Martin Brenner, CEO and Chief Scientific Officer of iBio, is focused on the untapped potential of therapeutic antibodies for obesity and cardiometabolic diseases. Leveraging AI and machine learning, iBio is streamlining the antibody discovery and optimization process and addressing the need for more complex antibody mechanisms of action. Their lead candidate, iBio 600, is an anti-myostatin antibody designed to address the side effects of muscle mass and bone density loss associated with current

en

0:00

AI Tool Improves Lung Cancer Diagnosis by Better...

Empowered Patient Podcast ·

2025/04/17

Dr. Lauren Parks Nicola, Chief Medical Officer at RevealDx, has extensive experience dealing with the challenges of accurately describing lung nodules and distinguishing between benign and malignant nodules based on visual inspection of CT scans. RevealDx software tool integrates into the radiologists' workflow and uses advanced algorithms and a large database of lung nodule data to provide a malignancy score for lung nodules. This technology can help reduce unnecessary follow-up scans and invasive

en

16:23

AI Tool Improves Lung Cancer Diagnosis by Better...

Empowered Patient Podcast ·

2025/04/17

Dr. Lauren Parks Nicola, Chief Medical Officer at RevealDx, has extensive experience dealing with the challenges of accurately describing lung nodules and distinguishing between benign and malignant nodules based on visual inspection of CT scans. RevealDx software tool integrates into the radiologists' workflow and uses advanced algorithms and a large database of lung nodule data to provide a malignancy score for lung nodules. This technology can help reduce unnecessary follow-up scans and invasive

en

0:00

Harnessing the First Responders of the Immune System...

Empowered Patient Podcast ·

2025/04/16

Daniel Getts, the CEO and Founder of Myeloid Therapeutics, is focused on the role of myeloid cells in the immune response to solid tumors. These cells are the first responders in the immune system and play a crucial role in bridging the innate and adaptive immune response. The Myeloid Therapeutics' mRNA technology activates myeloid cells in tumors, making the tumor microenvironment hot and attracting other immune cells to fight the cancer. Daniel explains, "The ability to harness our immune systems

en

19:17

Harnessing the First Responders of the Immune System...

Empowered Patient Podcast ·

2025/04/16

Daniel Getts, the CEO and Founder of Myeloid Therapeutics is focused on the role of myeloid cells in the immune response to solid tumors. These cells are the first responders in the immune system and play a crucial role in bridging the innate and adaptive immune response. The Myeloid Therapeutics' mRNA technology activates myeloid cells in tumors, making the tumor microenvironment hot and attracting other immune cells to fight the cancer. Daniel explains, "The ability to harness our immune systems

en

0:00

Navigating the Rapidly Evolving Healthcare...

Empowered Patient Podcast ·

2025/04/15

Saul Marquez, Founder and CEO of Outcomes Rocket, emphasizes the need for strategic healthcare communications, including earned media and paid advertising, content creation, and social influencers. The explosion of social media and online news outlets has changed the healthcare information environment, challenging companies to express authentic and intentional messages to their target audience. Identifying pain points and unique propositions is key to effective healthcare messaging that persuades,

en

19:30

Navigating the Rapidly Evolving Healthcare...

Empowered Patient Podcast ·

2025/04/15

Saul Marquez, Founder and CEO of Outcomes Rocket, emphasizes the need for strategic healthcare communications, including earned media and paid advertising, content creation, and social influencers. The explosion of social media and online news outlets has changed the healthcare information environment, challenging companies to express authentic and intentional messages to their target audience. Identifying pain points and unique propositions is key to effective healthcare messaging that persuades,

en

0:00

Patient-Centric Approach to Clinical Trial Enrollment...

Empowered Patient Podcast ·

2025/04/14

Robert Maxwell, Founder of ClinConnect, is building this neutral third-party intermediary between patients and clinical trial sponsors, improving on the clinicaltrials.gov platform by streamlining the clinical trial enrollment process. This patient-facing platform provides patients with up-to-date information about trial options and eligibility criteria and guides them through the enrollment process. This resource is particularly significant for the rare disease community, where ClinConnect works

en

22:29

Patient-Centric Approach to Clinical Trial Enrollment...

Empowered Patient Podcast ·

2025/04/14

Robert Maxwell, Founder of ClinConnect, is building this neutral third-party intermediary between patients and clinical trial sponsors, improving on the clinicaltrials.gov platform by streamlining the clinical trial enrollment process. This patient-facing platform provides patients with up-to-date information about trial options and eligibility criteria and guides them through the enrollment process. This resource is particularly significant for the rare disease community, where ClinConnect works

en

0:00

AI Enabling Radiologists and Patients to Identify...

Empowered Patient Podcast ·

2025/04/10

Angela Adams, CEO at Inflo Health, is addressing the opportunity to improve the tracking and follow-up of radiology findings. Info Health uses natural language processing to understand radiologists' reports and identify findings that require additional imaging and possible actions. Healthcare providers often lack the resources to manage radiology test results effectively. Inflo Health's solution can drive significant revenue to these providers by minimizing missed follow-ups and appointments

en

19:39

AI Enabling Radiologists and Patients to Identify...

Empowered Patient Podcast ·

2025/04/10

Angela Adams, CEO at Inflo Health, is addressing the opportunity to improve the tracking and follow-up of radiology findings. Info Health uses natural language processing to understand radiologists' reports and identify findings that require additional imaging and possible actions. Healthcare providers often lack the resources to manage radiology test results effectively. Inflo Health's solution can drive significant revenue to these providers by minimizing missed follow-ups and appointments

en

0:00

Stem Cell Therapy Targeting Alzheimer’s and Other...

Empowered Patient Podcast ·

2025/04/09

Dr. Chris Duma, President and Founder of Regeneration Biomedical, is developing stem cell therapies to treat neurodegenerative diseases like Alzheimer's, ALS, and multiple sclerosis. Their approach involves directly injecting the patient's stem cells into the brain ventricles to stimulate the brain's innate stem cells to repair and replace damaged neurons. Current clinical trials are showing promising results and, notably, minimal side effects compared to other Alzheimer's drugs. Chris explains,

en

19:26

Stem Cell Therapy Targeting Alzheimer’s and Other...

Empowered Patient Podcast ·

2025/04/09

Dr. Chris Duma, President and Founder of Regeneration Biomedical, is developing stem cell therapies to treat neurodegenerative diseases like Alzheimer's, ALS, and multiple sclerosis. Their approach involves directly injecting the patient's stem cells into the brain ventricles to stimulate the brain's innate stem cells to repair and replace damaged neurons. Current clinical trials are showing promising results and, notably, minimal side effects compared to other Alzheimer's drugs. Chris explains,

en

0:00

Gamma Delta T Cell Therapies to Target Solid Tumors...

Empowered Patient Podcast ·

2025/04/08

Will Ho, President, CEO, and Co-Founder of IN8bio, a company developing next-generation cellular therapies using gamma delta T cells, which play a unique role in bridging the innate and adaptive immune systems. GDT cell therapies may have reduced side effects compared to other T cell therapies as they can more selectively target tumor cells while sparing healthy tissue. IN8bio is conducting clinical trials using autologous and allogeneic gamma delta T cells for leukemia and glioblastoma with the

en

23:03

Gamma Delta T Cell Therapies to Target Solid Tumors...

Empowered Patient Podcast ·

2025/04/08

Will Ho, President, CEO, and Co-Founder of IN8bio, a company developing next-generation cellular therapies using gamma delta T cells, which play a unique role in bridging the innate and adaptive immune systems. GDT cell therapies may have reduced side effects compared to other T cell therapies as they can more selectively target tumor cells while sparing healthy tissue. IN8bio is conducting clinical trials using autologous and allogeneic gamma delta T cells for leukemia and glioblastoma with the

en

2,498 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown